Background: With the advance of medical care, chronic non-communicable diseases, like chronic kidney disease (CKD), have become the predominant diseases around the world. With heavy society and economy burden, we shall make full use of chronic disease management, including precision therapies. And the prerequisite for implementing precision medicine is to fully understand the characteristics of patients. Being the basis of the Knowledge-Attitude-Practice Model, patient's awareness is essential to conduct individualized treatments. However, there have been no validated questionnaires specific to the awareness of patients with CKD. Therefore, this study aims to develop and validate an awareness questionnaire for patients with CKD.
Methods: From March 2013 to September 2014, a cross-sectional study was conducted at Guangdong Provincial Hospital of Chinese Medicine. Age 18 or above were enrolled in the study. After signing the informed consent, they received a self-developed questionnaire to evaluate their CKD-related awareness. Then we collected their demographic data for further analyses. We also conducted item analyses/ validity and reliability analysis to filter out improper items and to retain the eligible ones.
Results: We totally distributed 110 copies of the questionnaires and 100 of them were returned. After item analyses, 2 items were excluded because of Cronbach's Alpha analysis. In total, 18 items were retained, comprising the final set of the questionnaire. For validity analysis, 4 components could explain the cumulative 73.966% extraction sums of the squared loadings; for reliability analysis, the Guttman Split-Half coefficient was 0.918.
Conclusions: This awareness questionnaire has favorable validity and reliability. It is a sound method for evaluating and measuring levels of disease-related awareness in CKD patients.
The authors have declared that no competing interests exist.
Al-Mohaithef M. Al-Mohaithef M. F1000Res. 2021 Jun 14;10:470. doi: 10.12688/f1000research.52997.2. eCollection 2021. F1000Res. 2021. PMID: 34900229 Free PMC article.
Gheewala PA, Peterson GM, Zaidi STR, Jose MD, Castelino RL. Gheewala PA, et al. BMC Public Health. 2018 Mar 20;18(1):371. doi: 10.1186/s12889-018-5301-4. BMC Public Health. 2018. PMID: 29554891 Free PMC article.
Khalil AA, Al-Modallal HM, Abdalrahim MS, Arabiat DH, Abed MA, Zeilani RS. Khalil AA, et al. Ren Fail. 2014 Sep;36(8):1200-7. doi: 10.3109/0886022X.2014.928969. Epub 2014 Jun 30. Ren Fail. 2014. PMID: 24975825
Luo L, Zhang M, Chen HF, Tang F, Fu LZ, Zhang DJ, Xia BQ, Dong CD, Xu YM, Wang LL, Lei N, Liu XS, Wu YF. Luo L, et al. Postgrad Med. 2021 Jan;133(1):48-56. doi: 10.1080/00325481.2020.1801029. Epub 2020 Aug 6. Postgrad Med. 2021. PMID: 32758047
Shi Y, Pu S, Peng H, Luo Y. Shi Y, et al. Int Urol Nephrol. 2024 Feb;56(2):653-665. doi: 10.1007/s11255-023-03702-1. Epub 2023 Jul 15. Int Urol Nephrol. 2024. PMID: 37452989 Free PMC article. Review.
Orozco T, Segal E, Hinkamp C, Olaoye O, Shell P, Shukla AM. Orozco T, et al. PLoS One. 2022 Sep 9;17(9):e0269488. doi: 10.1371/journal.pone.0269488. eCollection 2022. PLoS One. 2022. PMID: 36083893 Free PMC article.
Younes S, Mourad N, Safwan J, Dabbous M, Rahal M, Al Nabulsi M, Sakr F. Younes S, et al. BMC Nephrol. 2022 Jul 26;23(1):266. doi: 10.1186/s12882-022-02889-2. BMC Nephrol. 2022. PMID: 35883118 Free PMC article.
Alshogran OY, Hajjar MH, Muflih SM, Alzoubi KH. Alshogran OY, et al. Int J Clin Pharm. 2022 Oct;44(5):1169-1178. doi: 10.1007/s11096-022-01453-0. Epub 2022 Jul 12. Int J Clin Pharm. 2022. PMID: 35821552 Clinical Trial.
Ahmed J, Azhar S, Ul Haq N, Hussain S, Stájer A, Urbán E, Gajdács M, Jamshed S. Ahmed J, et al. Int J Environ Res Public Health. 2022 Apr 20;19(9):5015. doi: 10.3390/ijerph19095015. Int J Environ Res Public Health. 2022. PMID: 35564416 Free PMC article.
Ouyang WW, Chen HF, Xu XY, Zhang XL, Fu LZ, Tang F, Wen ZH, Marrone G, Liu LC, Lin JX, Liu XS, Wu YF. Ouyang WW, et al. BMC Nephrol. 2022 Mar 5;23(1):93. doi: 10.1186/s12882-022-02700-2. BMC Nephrol. 2022. PMID: 35247988 Free PMC article.